Sharon Brownlow

Chief Business Officer, Cell & Gene Therapy Catapult

Sharon is Chief Business Officer at the Cell & Gene Therapy Catapult, which is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, the Catapult’s mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early-stage research into commercially viable and investable therapies.

Sharon led the commercial operations at the CGT Catapult manufacturing centre in Stevenage for over three years. In this time, she played a pivotal role in securing collaborative research funding with partners and supporting the growth and productivity of the Manufacturing Centre.

She has an academic background in biophysics and postdoctoral research, followed by 30 years’ experience in biotechnology including strategic leadership and commercial roles with technology suppliers and contract development and manufacturing organisations.